Skip to main content

Juvenile Idiopathic Arthritis

  • Chapter
  • First Online:
Book cover Care of Adults with Chronic Childhood Conditions
  • 770 Accesses

Abstract

Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammatory arthritis in children and many patients have active disease that persists into adulthood. There are differences in the classification and management of JIA in comparison to adult-onset arthritis. Many patients will be taking immunosuppressive medications when they transition to adult care. In addition, they are at risk for comorbid conditions related to bone health, cardiovascular disease, reproductive health, medication toxicity, and complications from their arthritis. Primary care providers have an important role in the care of young adults with JIA. Being knowledgeable about this condition will assist them in anticipating, preventing, and treating late effects of this pediatric-onset condition. This chapter discusses the areas adult providers should consider when caring for young adults with juvenile idiopathic arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. U.S. Department of Education, Office for Civil Rights. Students with disabilities preparing for postsecondary education: know your rights and responsibilities http://www2.ed.gov/about/offices/list/ocr/transition.html. Accessed 13 June 2016.

  2. Centers for Disease Control and Prevention. Adult immunization schedules. http://www.cdc.gov/vaccines/schedules/hcp/adult.html Accessed 7 May 2016.

  3. Cauffman E, Steinberg L. (Im)maturity of judgment in adolescence: why adolescents may be less culpable than adults. Behav Sci Law. 2000;18(6):741–60.

    Article  CAS  PubMed  Google Scholar 

  4. ACP High Value Care JIA. https://www.acponline.org/system/files/documents/clinical_information/high_value_care/clinician_resources/pediatric_adult_care_transitions/rheumatology/jia_transition_tools.pdf. Accessed 7 May 2016.

  5. Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26.

    Article  PubMed  Google Scholar 

  6. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.

    PubMed  Google Scholar 

  7. Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Cassidy JT, editors. Textbook of pediatric rheumatology. 7th ed. Philadelphia: Elsevier; 2016.

    Google Scholar 

  8. Coulson EJ, Hanson HJM, Foster HE. What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatol Oxf Engl. 2014;53(12):2155–66.

    Article  Google Scholar 

  9. Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343–8.

    PubMed  Google Scholar 

  10. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet Lond Engl. 2007;369(9563):767–78.

    Article  CAS  Google Scholar 

  11. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K, German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatol Oxf Engl. 2007;46(6):1015–9.

    Google Scholar 

  12. Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, et al. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;10(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 2007;56(6):1974–84.

    Article  CAS  PubMed  Google Scholar 

  14. Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DPM. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Arthritis Care Res. 2010;62(5):664–75.

    Article  Google Scholar 

  15. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatol Oxf Engl. 2002;41(12):1428–35.

    Article  CAS  Google Scholar 

  16. Gomez KS, Raza K, Jones SD, Kennedy LG, Calin A. Juvenile onset ankylosing spondylitis—more girls than we thought? J Rheumatol. 1997;24(4):735–7.

    CAS  PubMed  Google Scholar 

  17. Hersh A, von Scheven E, Yelin E. Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol. 2011;7(5):290–5.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Flatø B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol. 2009;36(3):642–50.

    Article  PubMed  Google Scholar 

  19. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465–82.

    Article  Google Scholar 

  20. Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773–80.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(4):1263–71.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ringold S, Cron RQ. The temporomandibular joint in juvenile idiopathic arthritis: frequently used and frequently arthritic. Pediatr Rheumatol. 2009;7(1):11.

    Article  Google Scholar 

  23. Hospach T, Maier J, Müller-Abt P, Patel A, Horneff G, von Kalle T. Cervical spine involvement in patients with juvenile idiopathic arthritis—MRI follow-up study. Pediatr Rheumatol Online J. 2014;4(12):9.

    Article  Google Scholar 

  24. Bohr A-H, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Müller K. Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J. 2016;14. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704268/ Accessed 10 May 2016.

  25. Coulson EJ, Ng W-F, Goff I, Foster HE. Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology. 2013 Mar 15;ket106.

    Google Scholar 

  26. Feldman DE, Vinet É, Bérard A, Duffy C, Hazel B, Meshefedjian G, et al. Heart disease, hypertension, gestational diabetes and pre-eclampsia/eclampsia in mothers with juvenile arthritis: a nested case-control study. Arthritis Care Res. 2016 (Epub ahead of print) PMID: 27111101.

    Google Scholar 

  27. Anderson JH, Anderson KR, Aulie HA, Crowson CS, Mason TG, Ardoin SP, et al. Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. Scand J Rheumatol. 2016;8:1–5.

    Article  Google Scholar 

  28. Pelajo CF, Lopez-Benitez JM, Miller LC. Obesity and disease activity in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;12(10):3.

    Article  Google Scholar 

  29. Pincus T, Gibson KA, Block JA. Premature mortality: a neglected outcome in rheumatic diseases? Arthritis Care Res. 2015;67(8):1043–6.

    Article  Google Scholar 

  30. Bouayed K, Alyanakian M-A, Cordonnier C, Caillat-Zucman S, Testelin S, Lambrey G, et al. Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritis. Rheumatology. 2002;41(10):1190–3.

    Article  CAS  PubMed  Google Scholar 

  31. Cassidy JT, Hillman LS. Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis. Rheum Dis Clin N Am. 1997;23(3):499–522.

    Article  CAS  Google Scholar 

  32. Zak M, Hassager C, Lovell DJ, Nielsen S, Henderson CJ, Pedersen FK. Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthritis Rheum. 1999;42(4):790–8.

    Article  CAS  PubMed  Google Scholar 

  33. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds); Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Food and Nutrition Board; Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press. 2011. http://www.nap.edu/catalog/13050/dietary-reference-intakes-for-calcium-and-vitamin-d Accessed 10 May 2016.

  34. Jetha A, Badley E, Beaton D, Fortin PR, Shiff NJ, Gignac MAM. Unpacking early work experiences of young adults with rheumatic disease: an examination of absenteeism, job disruptions and productivity loss. Arthritis Care Res. 2015;67(9):1246–54.

    Article  Google Scholar 

  35. Jetha A. The impact of arthritis on the early employment experiences of young adults: a literature review. Disabil Health J. 2015;8(3):317–24.

    Article  PubMed  Google Scholar 

  36. Barth S, Haas J-P, Schlichtiger J, Molz J, Bisdorff B, Michels H, et al. Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS ONE. 2016;11(4):e0153267.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg B-Y, Koldingsnes W, et al. Fertility in women with chronic inflammatory arthritides. Rheumatol Oxf Engl. 2011;50(6):1162–7.

    Article  Google Scholar 

  38. Farr SL, Folger SG, Paulen ME, Curtis KM. Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review. Contraception. 2010;82(1):64–71.

    Article  PubMed  Google Scholar 

  39. Schikler KN. Is it juvenile rheumatoid arthritis or fibromyalgia? Med Clin N Am. 2000;84(4):967–82.

    Article  CAS  PubMed  Google Scholar 

  40. Anthony KK, Schanberg LE. Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease. Pediatr Clin N Am. 2005;52(2):611–39, vii.

    Google Scholar 

  41. White PH, Ardoin S. Transitioning wisely: improving the connection from pediatric to adult health care. Arthritis Rheumatol. 2016;68(4):789–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tova Ronis .

Editor information

Editors and Affiliations

Appendix

Appendix

Juvenile Idiopathic Arthritis (JIA) condition fact Sheet

Definition

JIA is an autoimmune disease defined by arthritis occurring for greater than 6 weeks in a child younger than 16

 • Subtypes of JIA include: systemic, oligoarticular, polyarticular (rheumatoid factor positive or negative), enthesitis-related arthritis, psoriatic arthritis, and undifferentiated

 • Each subtype of JIA has a different presentation

Epidemiology

 • Prevalence of JIA ranges from 10 to 400 per 100,000 around the world

 • There is overall a 2:1 female-to-male ratio

 • Oligoarthritis is the most common subtype of childhood arthritis affecting 50–80 % of all children with chronic arthritis

 • A substantial number of JIA patients continue to have active arthritis into adulthood

Special considerations

Individuals with JIA are at risk for comorbid physical and mental health conditions, including

 • Persistent arthritis

 • Growth abnormalities

 • Ocular complications

 • Medication toxicity including infection, teratogenic risk

 • Anxiety and depression

 • Macrophage activation syndrome

 • Chronic pain

Individuals are at heightened risk for chronic conditions, including

 • Uveitis

 • Atherosclerosis and coronary heart disease

 • Osteoporosis and fractures

 • Osteoarthritis

 • Malignancy

 • Need for joint replacement surgery

 • Sjögren’s syndrome

Recommended screening

Patients may require lab screening for medication side effects

Suggested Reading List

  • Petty RE, Laxer RM, Lindsley CB, Wedderburn L, Cassidy JT (eds). Textbook of pediatric rheumatology, Seventh edition. Philadelphia, PA: Elsevier. 2016

  • Espinosa M, Gottlieb BS. Juvenile Idiopathic Arthritis. Pediatr. Rev. 2012;33, 303–313.

  • Coulson EJ, Hanson HJM, Foster HE. What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatol Oxf Engl. 2014 Dec;53(12):2155–66.

Patient/Caregiver/Provider Resources

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ronis, T., White, P.H. (2016). Juvenile Idiopathic Arthritis. In: Pilapil, M., DeLaet, D., Kuo, A., Peacock, C., Sharma, N. (eds) Care of Adults with Chronic Childhood Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-43827-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43827-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43825-2

  • Online ISBN: 978-3-319-43827-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics